From shortage to success: How MUSC anesthesia team navigated IV fluid crisis

As we approach the first anniversary of flooding from Hurricane Helene that devastated parts of North Carolina, the ...

IV Solution & Ketamine Centers of Chicago Highlights Intravenous Ketamine Therapy Through Patient Stories

IV Solution and Ketamine Centers of Chicago continues to demonstrate the transformative impact of its specialized mental health treatments through documented patient outcomes shared across multiple ...

Sick Patient With Just $6 In Savings Says They're Too Poor to Eat And Asks, 'Will the Hospital Feed Me?' As They Debate Going To ER In Hopes Of A Meal

When most people think about going to the hospital, they're worried about the bill. One patient on Reddit had a far more ...

New reports highlight patient deaths as bidders plan to acquire CT hospitals

With bids for Prospect Medical Holdings’ three Connecticut hospitals expected, state Department of Public Health reports flag concerns at the private equity hospitals, including the death of an infant ...
Mena FN

Biorestore Expands Patient Services With Affordable IV Therapy Options

BioRestore Introduces Accessible IV Therapy to Enhance Patient Wellness Programs NEWTOWN, CT, UNITED STATES, September 15, 2025 /EINPresswire / -- BioRestore, a leading Connecticut-based medical ...

Merck: Initiating "Strong Buy" On Shift To Qlex SC Injection For Solid Tumors

Despite flat overall Q2 2025 sales, Keytruda's continued strong performance in oncology supports long-term bullish prospects ...
Pharmabiz

First study to compare two ketamine therapies for patients with severe depression

First study to compare two ketamine therapies for patients with severe depression: Boston, Massachusetts Monday, September 29, 2025, 11:00 Hrs [IST] In a new study, investigators ...

Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Tra…

A first-in-class LRP1 agonist, SP16 phase 1b Chemotherapy Induced Neuropathy (CIPN) Study fully funded by the National Cancer ...

Kedrion Biopharma Receives FDA Approval for QIVIGY® (Immune Globulin 10% IV) for treatment of Primary Humoral Immunodeficiency in Adults and confirms its plan …

Kedrion Biopharma announced today that it has received FDA approval for QIVIGY immune globulin intravenous (human)-kthm 10% ...
EurekAlert!

Study finds two forms of ketamine therapy can reduce symptom severity in patients with treatment-resistant depression

Mass General Brigham investigators compared the effects of intravenous (IV) ketamine and intranasal (IN) esketamine in 153 patients with treatment-resistant depression in a naturalistic study, finding ...
WCIV on MSN

Pawsitive healing: hospital dog brings comfort & joy to young patients at MUSC

Being in a hospital can be nerve wracking and stressful, but patients at MUSC's Shawn Jenkins Children's Hospital have a furry friend in their time of need.Dogs ...